SCHEMBL5474669

SCHEMBL5474669

OC1(c2ccccc2)c2ccccc2Oc2ccc(Br)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.49
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PDK2 Q15119 1/20 0.39
CHRM3 P20309 1/20 0.38
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
P2RX1 P51575 1/20 0.36
P2RX3 P56373 1/20 0.36
P2RX4 Q99571 1/20 0.36
P2RX7 Q99572 1/20 0.36
AKR1B1 P15121 1/20 0.34
HSP90AA1 P07900 2/20 0.33
LMNA P02545 1/20 0.33
ALPL P05186 1/20 0.33
ALPI P09923 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29722 0.85 CHRM3 (0.46) AHRMEN1KMT2ACHRM3P2RX1
SCHEMBL17175633 0.82 AHR (0.44) AHROPRM1OPRD1PDK2CHRM3
SCHEMBL15713660 0.81 AHR (0.52) AHROPRM1OPRD1MEN1KMT2A
SCHEMBL29948098 0.80 PDK2 (0.45) OPRM1OPRD1MEN1KMT2APDK2
SCHEMBL390934 0.80 PDK2 (0.45) OPRM1OPRD1MEN1KMT2APDK2
SCHEMBL20212020 0.78 AHR (0.52) AHROPRM1OPRD1MEN1KMT2A
SCHEMBL15713413 0.78 AHR (0.49) AHROPRM1OPRD1MEN1KMT2A
SCHEMBL824255 0.78 MEN1 (0.46) OPRM1OPRD1MEN1KMT2APDK2
SCHEMBL4585510 0.78 MEN1 (0.46) OPRM1OPRD1MEN1KMT2APDK2
SCHEMBL23420604 0.76 AHR (0.59) AHROPRM1OPRD1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276139-A1 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis ISIS PHARMACEUTICALS, INC. 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276139-A1 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis RPP30, NOP10, NR0B1 AHR 2376/4885OPRM1 272/4885OPRD1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.